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Abstract
Background: Thirdhand smoke (THS) is the persistent residue resulting from secondhand smoke (SHS) that
accumulates in dust, objects, and on surfaces in homes where tobacco has been used, and is reemitted into air.
Very little is known about the extent to which THS contributes to children’s overall tobacco smoke exposure (OTS)
levels, defined as their combined THS and SHS exposure. Even less is known about the effect of OTS and THS on
children’s health. This project will examine how different home smoking behaviors contribute to THS and OTS and
if levels of THS are associated with respiratory illnesses in nonsmoking children.
Methods: This project leverages the experimental design from an ongoing pediatric emergency department-based
tobacco cessation trial of caregivers who smoke and their children (NIHR01HD083354). At baseline and follow-up,
we will collect urine and handwipe samples from children and samples of dust and air from the homes of smokers
who smoke indoors, have smoking bans or who have quit smoking. These samples will be analyzed to examine to
what extent THS pollution at home contributes to OTS exposure over and above SHS and to what extent THS
continues to persist and contribute to OTS in homes of smokers who have quit or have smoking bans. Targeted
and nontargeted chemical analyses of home dust samples will explore which types of THS pollutants are present in
homes. Electronic medical record review will examine if THS and OTS levels are associated with child respiratory
illness. Additionally, a repository of child and environmental samples will be created.
Discussion: The results of this study will be crucial to help close gaps in our understanding of the types, quantity,
and clinical effects of OTS, THS exposure, and THS pollutants in a unique sample of tobacco smoke-exposed ill
children and their homes. The potential impact of these findings is substantial, as currently the level of risk in OTS
attributable to THS is unknown. This research has the potential to change how we protect children from OTS, by
recognizing that SHS and THS exposure needs to be addressed separately and jointly as sources of pollution and
exposure.
Trial registration: ClinicalTrials.gov Identifier: NCT02531594. Date of registration: August 24, 2015.
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Background
Thirdhand smoke (THS) is the persistent residue
resulting from secondhand smoke (SHS) that accumu-
lates in dust, objects, and on surfaces in homes where
tobacco has been used, and is re-emitted into the air [1,
2]. Our research indicates that smoker’s homes become
reservoirs of persistent toxic pollutants, such as nico-
tine, polycyclic aromatic hydrocarbons (PAH), and the
highly carcinogenic tobacco-specific nitrosamines
(TSNAs). Some THS pollutants continue to undergo
further chemical changes in the home. Specifically,
semi-volatile tobacco smoke compounds can adsorb
into carpets, furnishings, and walls where they may
react with ambient oxidants (e.g., nitrous acid) to create
novel toxicants, some of which are human carcinogens
[1–4]. Children are exposed to THS toxicants via inhal-
ation, ingestion, and dermal transfer from THS reser-
voirs, and children of smokers carry THS pollutants on
their hands [5–7]. Children are more sensitive to pol-
lutants than adults [8–10] and much more exposed to
house dust than adults [11–13]. Even in homes with
smoking bans, children have 5-7 times more nicotine
exposure than in nonsmoking homes [5]; levels are
higher in apartments [14]. In toddlers, nicotine and
TSNA exposure from THS is up to 16 times higher
[15] than adults through inhalation of SHS, and THS
may cause hazardous health effects [4, 16–18].
Very little is known about the extent to which THS
contributes to nonsmoking children’s overall levels of
tobacco smoke exposure (OTS), defined as their com-
bined THS and SHS exposure. Even less is known
about the effect of OTS and THS on child health. Such
knowledge is crucial so that remediation strategies can
be developed to protect children from SHS and THS
pollutants. Building on prior research and leveraging
the experimental design from an active tobacco cessa-
tion trial of caregivers who smoke and their children
(NIHR01HD083354), we will examine how home smok-
ing behaviors contribute to THS and OTS pollution
and exposure. Specifically, we will determine to what
extent home THS contributes to OTS exposure over
and above SHS and to what extent THS continues to
linger and lead to OTS in homes with smoking bans
and in homes after smokers quit. Targeted and novel
nontargeted analyses of home dust samples will explore
which types of THS pollutants are present. We will ex-
plore if child handwipe samples can provide valid
markers of THS pollutants in the child’s home environ-
ment. Electronic medical record (EMR) review will be
conducted to examine if THS and OTS levels are asso-
ciated with child respiratory illness. Additionally, a re-
pository of biological and environmental samples from
smoke exposed children will be created for research on
SHS, THS, and OTS.
Aims and Hypotheses
Primary Aim 1
To examine the contribution of THS in children’s envi-
ronments to their OTS exposure. Samples will be ana-
lyzed at baseline (T0) and 6-weeks after a smoking
cessation intervention (T1) to assess THS pollution
(nicotine from handwipe samples; dust NNK, nicotine,
nicotelline) and biomarkers of child OTS (urinary cotin-
ine, NNAL) and THS exposure (urinary NNAL/cotinine
and N-Oxides/cotinine ratios).
Hypothesis 1.1 At T0, higher levels of THS pollution
will be associated with higher levels of OTS and THS
exposure markers, controlling for number of smokers
and cigarettes smoked, and home smoking restrictions.
Hypothesis 1.2 At T1, children of quitters will have sig-
nificantly lower levels of OTS exposure than at T0; T1
levels of THS exposure will be significantly above levels
of children in nonsmoker’s homes.
Specific Aim 2
To determine the levels and composition of THS pollut-
ants in house dust 6-weeks (T1) and 6-months (T2) after
a cessation intervention. Dust will undergo analysis for
tobacco carcinogens (TSNAs, PAHs), and novel nontar-
geted analyses to comprehensively characterize the mix-
ture of chemicals that make up THS.
Hypothesis 2.1 Higher levels of nicotine and TSNAs in
dust at T1 will be associated with continued smoking at
T1, controlling for cigarettes smoked, home smoking re-
strictions, and T0 hand nicotine levels.
Hypothesis 2.2 Nontargeted analyses of dust from
homes of those who quit or who have established
complete smoking bans at T2 will have a higher propor-
tion of novel secondary THS pollutants at T2 compared
to T1. Targeted and nontargeted dust analyses from
homes of continued smokers will have higher levels of
THS pollutants and similar mixtures at T1 and T2.
Exploratory Hypothesis 2.3 Child hand nicotine levels
may serve as tracers of other THS pollutants in the
home and markers of THS exposure as determined by
targeted and nontargeted analyses of dust and targeted
analyses of urine samples at T1 and T2.
Specific Aim 3
To examine child and smoking factors associated with
THS and OTS levels and to examine if levels are associ-
ated with respiratory-related diagnoses, interventions,
tests, and Pediatric Emergency Department (PED)/Ur-
gent Care (UC) visits.
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Hypothesis 3.1 Higher levels of THS and OTS will be
present in children who: are younger, live in apartments,
live with more smokers and more cigarettes smoked;
have higher rates of respiratory related diagnoses (e.g.,
asthma), interventions (e.g., oxygen, antibiotics), and
positive tests (e.g., pneumonia).
Hypothesis 3.2 Children of smokers will have higher
rates of pediatric emergency or urgent care visits than
children of nonsmokers.
Secondary Aim 1
To create a repository of biological and environmental
samples of smoke exposed children and their home
environments.
Methods/Design
Overview of study design
The proposed study will leverage the study design, op-
erational infrastructure, and collection and storage of
samples of an ongoing, IRB approved, two-group ran-
domized controlled trial (R01HD083354) [19]. This trial
is designed to test the efficacy of a Screening, Brief
Intervention, and Referral to Treatment (SBIRT) to-
bacco cessation intervention compared to an active
control condition on caregivers who smoke who bring
their child to the PED or UC at Cincinnati Children’s
Hospital Medical Center (CCHMC). Caregivers ran-
domized to the SBIRT condition receive face-to-face,
tailored counseling that focuses on the child’s illness,
the importance of reducing child SHS, caregiver smok-
ing cessation, and the option to receive 12 weeks of
nicotine replacement therapy. Caregivers randomized
to the Healthy Habit Control (HHC) condition receive
healthy lifestyle information that focuses on improving
their child’s health by encouraging the “Let’s Go!
5-2-1-0” health practices [20]. Child participants are
patients in the PED/UC who are nonsmokers and
present with a potentially SHS-related complaint (e.g.,
cough, congestion). In this project, we will conduct sec-
ondary analyses on caregiver assessments and child bio-
logical and environmental samples that are not being
analyzed from R01HD083354, and child clinical data
abstracted from the EMRs of child participants.
Electronic self-report assessments are conducted
in-person at baseline (T0) as part of R01HD083354 and
via email or phone with verification of responses
in-person during home visits at 6-weeks (T1) on all par-
ticipants. For this project, home visits also occur at
6-months (T2) on 30 caregivers who are continued
smokers and 30 caregivers who report that they have
quit or have established complete smoking bans at T2.
Consent includes permission to collect and store add-
itional and leftover samples in a secure repository for
potential future research. See Table 1 for the data collec-
tion and analysis plan by research aim.
Participant Inclusion/Exclusion Criteria
Adult participants are required to meet the following
criteria in order to be eligible for enrollment in the trial:
(1) Children and caregivers must have been enrolled at
the T0 PED/UC visit as part of R01HD083354
(2) Age 18 or older
(3) Daily smoker at T0
(4) English literate
(5) Have a working cell or landline number
(6) Caregivers and children must have a complete set
of data and samples defined as: (a) caregiver
Table 1 Schedule of enrollment, interventions, and assessments
Time Point Study Period
Enrollment Allocation Post-allocation
Baseline
T0
Baseline
T0
6-weeks
T1
6-months
T2
Enrollment
Eligibility Screen X
Informed
Consent/Assent
X X
Allocation X
Interventions
Intervention
Group (SBIRT)
X
Control Group (HHC) X
Assessments
Sociodemographics X X
Smoking history,
Smoking Behavior,
quit attempts
X X X
Parent reported
Child TSE
X X X
EMR Review of
Children TSE-related
healthcare visits
X X X
Verification of
quitting (exhaled
carbon monoxide)
X X
Verification of Child
SHS exposure
(urinary cotinine)
X X X
Sample Collection
Urine X X X
Handwipes X X X
Dust X X
Air Monitor Xa
aAir Monitor is picked up approximately 1 week after T2
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assessments plus: (b) child handwipes and (c) child
urine at T0 and at T1 and (d) house dust at T1
Exclusion criteria:
(1) Tobacco chewers only
(2) Live more than 50 miles away
(3) Plan to move with no permanent address within 6
months of enrollment at T0
(4) Child is an active smoker or marijuana user
(5) Child is tracheostomy dependent
Study Procedures
Setting
Study procedures occur at the PED/UC of CCHMC and
at study participants’ homes.
Recruitment and study flow
Trained Clinical Research Coordinators (CRCs) obtain
informed consent for participation in T0 and again at
the T1 visit for participation in Aim 2. During the home
visit at T1, the CRC will explain study procedures rele-
vant to Aim 2 to eligible caregivers. Since we need 30
caregivers who are continued smokers and 30 who have
quit smoking or established complete smoking bans,
caregivers are told that they may be asked to participate
depending on their answers to questions at T2. Informed
consent will be obtained by the CRC; children over age
11 will provide assent. A secure database will be used
during enrollment times, which will include all patients
approached, with information on their age, sex, race,
chief complaint, enrollment status, and reasons for
non-enrollment (if applicable).
Randomization and treatment conditions
Participants were already randomized at T0 and remain
in either the SBIRT or HHC condition for the entire
study. Components of the SBIRT and HHC condition
are reported elsewhere [19].
Assessment procedures
Measures
Caregiver self-assessments are completed at T0, T1, and
T2. Assessments include measures of sociodemographics;
smoking history and smoking behavior: current tobacco
use, electronic cigarette use, number of household
smokers, numbers and location of cigarettes smoked; and
house type (e.g., multiunit or detached home). We will ex-
tract CCHMC EMR data from T0 including: demograph-
ics; past medical history and respiratory-related clinical
data such as ICD-10 diagnoses; clinical test and radio-
graph results (if any); interventions; respiratory assistance;
medications; and disposition. For Aim 3, Hypothesis 3.2,
we will also examine the frequency of PED or UC visits to
CCHMC for the 200 children 6-months to 17 years old
that are part of Aim 1 at T0 and for 6-months prior to T0,
using CCHMC’s EMR system Epic. This PED and UC visit
data will be compared to the same Epic data from an
age-and 6-month time period-matched sample of 200
non-tobacco exposed children that were identified during
R21CA184337 [21].
Primary and secondary outcome variables
We will obtain the following primary outcomes from the
sample analyses in Aim 1 and Aim 2: handwipe nicotine;
dust nicotine, nicotelline, TSNAs; urinary cotinine,
NNAL; urinary NNAL/cotinine and N-Oxides/cotinine
ratios. The primary outcomes for Aim 2 are the same as
Aim 1 and also include dust PAHs and the results of
untargeted analyses of dust. We will obtain the following
secondary outcomes in Aim 3: respiratory-related diag-
noses, interventions, tests, and PED/UC visits.
Covariates, mediators, and moderators
Covariates that will be considered in all analyses include
home type (i.e., multiunit home/apartment, single-family
home), child age and sex.
Sample collection and chemical analysis by sample type
Sample collection, specimen handling, and storage
Standardized protocols are used to collect all data and
samples at all visits. During the home visits, CRCs will
obtain detailed information about house characteristics
(e.g., measurements) and the room in which samples are
collected. Home environmental samples (i.e., home dust,
air monitors) will be collected in the room where the
most smoking occurs (for homes with smokers) or in
the room where the child spends the most time (for
homes with nonsmokers or homes with smoking bans).
Study staff and participants are blinded to results of
tests. All samples will be placed on ice and then proc-
essed and stored at -80°C at CCHMC until ready for
shipment. Samples will be shipped on dry ice via over-
night shipping to the Environmental Health Analytic
Chemistry Lab at San Diego State University (hand-
wipes, dust, air monitors) and the Clinical Pharmacology
Lab at the University of California San Francisco (urine
for nicotine, TSNA, and nicotelline metabolites). Once
at these laboratories, samples will be stored at -20°C
until ready for analysis.
Repository collection
To facilitate future novel scientific discovery of this
unique pediatric population of tobacco smoke exposed
children, we will collect and store de-identified, unana-
lyzed environmental and biological samples at -80°C and
corresponding datasets at T0-T2 on all participants who
consented to this at T0.
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Biological and environmental sample collection and
chemical analyses
Urine samples: OTS For Aims 1 and 2, approximately
>7 ml of urine is collected and aliquoted into cryovials;
samples will be analyzed for cotinine, NNAL and nicotel-
line N-Oxides, which are measures of OTS. Cotinine is a
biomarker of recent TSE [22]. NNAL is a metabolite of
the tobacco specific nitrosamine NNK, a marker of OTS
(SHS and THS) in nonsmokers, and a biomarker of expos-
ure to TSNA carcinogens [23]; the half-life is approxi-
mately 10 days. NNK in dust is a marker of THS.
N-Oxides are metabolites of nicotelline. In dust, nicotelline
is a THS marker for particulate matter (PM) derived from
tobacco smoke [24]. We will derive biomarkers for THS
exposure based on ratios of TSE biomarkers: NNAL/cotin-
ine and N-Oxide/cotinine. Urine samples will be analyzed
by LC-MS/MS; analytical methods are published [24–26].
Handwipes: THS pollution Handwipes will be analyzed
to measure nicotine, a marker of THS pollution on sur-
faces in the child’s home environment. THS handwipe
procedures have been established by us and used with
children and adults [5–7, 27, 28]. Taking a sample of
THS surface nicotine involves: (1) preparing a solution
of distilled water and 0.1% ascorbic acid (i.e., vitamin C);
(2) wetting a screened cotton round with the solution;
(3) wiping the palm and fingers of the dominant hand;
and (4) storing the wipe in a vial for further analysis.
Hand nicotine levels are reported in nanograms (ng) per
wipe. Following Quintana, et.al [27], field blanks are col-
lected to correct for any contamination from extraneous
sources. Wipe samples will be stored at -20°C in the
dark until analysis for nicotine. Nicotine in wipe samples
will be analyzed by LC-MS/MS. The sample preparation
and instrumental conditions have been reported previ-
ously [28–30]. We will measure the size of children’s
hands and assess the last time their hands were washed.
Dust Samples: Targeted Analyses Dust samples will be
analyzed using targeted methods to quantify levels of
nicotine, TSNAs (NNK, NNN, NAT, NAB), and nicotel-
line. Nicotine, TSNAs, and nicotelline are tobacco-specific
compounds representing gas and particulate phases of to-
bacco smoke. When detected in dust, they serve as envir-
onmental tracers of THS that have accumulated in settled
house dust. Dust samples will be collected using a stan-
dardized protocol. A 1m×1m area (or from a larger area, if
needed, to collect approximately 1cm of dust in collection
bottle) with a High-Volume-Small Surface-Sampler
(HVS4, CS3 Inc., Venice, FL) into methanol-washed Tef-
lon bottles. Dust samples will be weighed and sieved with
a stainless steel, methanol-washed, 150 micrometer mesh
sieve to remove large debris such as pet hairs, and
weighed again. Sieved dust samples will be analyzed by
isotope dilution LC-MS/MS. Detailed methods have been
published elsewhere [28, 30].
Dust Samples: Nontargeted Analyses We will deter-
mine the concentration of 16 priority PAHs as identified
by the U.S. Environmental Protection Agency, including
benzo[a]pyrene, chrysene, pyrene, fluorene, fluoranthene,
and naphthalene [31, 32]. Additional toxic PAHs will be
identified during the GCxGC/TOF-MS nontargeted ana-
lysis. We will employ a novel nontargeted analytical tech-
nique developed by Dr. Hoh as a core tool [33–35]. This
method is based on a comprehensive two-dimensional gas
chromatography coupled to time-of-flight mass spectrom-
etry (GCxGC/TOF-MS). GCxGC/TOF-MS has a superior
ability to identify compounds based on the enhanced sen-
sitivity and chromatographic separation power provided
by the GCxGC chromatography system and the simultan-
eous collection of ions at a fast data acquisition rate by the
TOF-MS [36, 37].
Air Samples Air samples will be placed at T2 in the room
chosen (see Sample Collection, Specimen Handling, and
Storage, above). A passive diffusion monitor badge will be
used, consisting of a modified 37mm 3M Organic Vapor
Monitor (3-M, St. Paul, MN) with a glass fiber filter
coated with a glycerol/phosphoric acid mixture (filter col-
lector will be modified from Kuusimaki, et al. [38]). The
CRC will tape an active monitor to a wall five feet above
ground, out of children’s reach and away from windows,
corners, and doors. Inactive monitors will be placed in all
other rooms to enhance reporting accuracy. CRCs will
conduct home visits approximately 7 days later to retrieve
the monitors, and the minutes the badge was placed will
be recorded. Field blanks will be collected and 10% will be
analyzed. Samples will be analyzed by isotope dilution
LC-MS/MS; extraction will take place as for handwipes,
see above [28, 30].
Participant Retention Strategies
Multiple strategies will be used to retain the sample in-
cluding: 1) Adequate incentives for their time: participants
will be paid with increasing compensation of $30 at T0,
$50 at T1 ($20 for the questionnaire, $30 for the home
visit), and $65 at T1 ($30 for the questionnaire, $35 for
the home visit), plus a bonus $10 if they complete both of
the follow-up assessments; 2) Conducting home visits on
caregivers and children at T1 at T2 to assess outcomes
and obtain samples, making study participation conveni-
ent for participants; 3) attempting to contact participants
up to 10 times after T0 to arrange follow-up visits; 4) con-
ducting “drop-in” unscheduled home visits on participants
we are unable to contact; and 5) options to complete care-
giver assessments via email.
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Data quality control
Quality control procedures will be implemented to as-
sure accurate and complete recording of survey re-
sponses, collection of environmental and biological
samples in the field, the analysis of samples in the la-
boratory, and database entry. All data will be screened
for missing and out-of-range responses, inconsistencies,
and distributional properties. Depending on the statis-
tical model used for a particular analysis, distributional
assumptions will be examined. If necessary, response
variables will be transformed for analysis (e.g., log trans-
formation to address heterogeneous variances) and alter-
native statistical models will be evaluated. We will
conduct sensitivity analyses comparing findings and con-
clusions from alternative approaches, including General
Estimating Equations when examining changes over
time, to optimize the number of subjects included re-
garding the dependent variable of interest. Validation
samples will be investigated to determine possible con-
tamination of samples in the field and sources of error
in the lab. This is a critical part of quality assurance ef-
forts when collecting environmental and biological
markers of SHS/THS pollution and exposure in the field.
Statistical analyses will be performed using the latest
versions of STATA, R, SAS, and SPSS software packages
[39, 40]. The Type I error rate will be set at α=.05 and
corrections will be performed as necessary.
Statistical analysis plan
Power analysis and sample size calculations
Sample sizes are based on our prior research of THS
pollutants and exposure in homes of smokers, non-
smokers, smokers who quit, and nonsmokers who move
into smoker’s homes. From this research, we expect: (a)
standardized mean differences comparing dust and sur-
face nicotine levels and urinary cotinine between homes
with active smoking and nonsmokers to be d=1.5-2.0
and between homes of smokers with and without indoor
smoking bans to be d=0.8-1.0; and (b) the proportion of
variance in exposure accounts for 3-7% of the overall
variance accounted for (R2=0.25 to 0.40) [41, 42]. Using
GPower, we determined that under the conservative sce-
nario (lower boundary estimates of above ranges),
N=200 at T0 and T1 will yield power>0.80. For the more
optimistic scenario (upper boundary estimates of above
ranges), power will be >0.90.
Aims, hypotheses, statistical analysis
The data-analytic approach relies on linear models for
cross-sectional and longitudinal designs. Each model will
evaluate important potential moderating and confound-
ing conditions, including the child age, sex, and home
(e.g. type, size, flooring, number of rooms). We will
examine how attrition may affect generalizability of
findings and statistical models may require adjustment
to control for potential biases.
Primary Aim 1 A multivariate multiple linear regression
model (command mvreg in Stata) will be used to investi-
gate if T0 hand nicotine levels (explanatory variable) are
independently associated with exposure (three response
variables: cotinine, NNAL, N-Oxides), controlling for
child age, child sex, number of smokers and cigarettes
smoked (including e-cigarettes), smoking bans, and type
and size of home. Categorical explanatory variables will
be dummy-coded and interaction effects with child sex
and age will be explored. Overall model fit statistics and
omnibus tests (R2, RMSE, omnibus F) will be evaluated,
and specific hypothesis tests will be conducted for each
of the explanatory variables of interest. A similar multi-
variate multiple linear regression model will also be esti-
mated to determine if T0 hand nicotine levels are
independently associated with THS exposure, controlling
for child age, child sex, number of smokers and ciga-
rettes smoked, smoking bans, and type of home.
To investigate if OTS levels in children of caregivers
who have quit or in children of caregivers who have
established smoking bans differ from known OTS levels
of nonsmokers, we will analyze whether the observed
mean OTS levels in the model above differ from the
known levels of cotinine and NNK from published stud-
ies (controlling for child age and sex). To compare OTS
levels at T1 and T0, we will use linear mixed models
(command mixed in Stata) with OTS markers (cotinine,
NNK, nicotelline) as response variables, subjects as the
random factor, and time as a fixed factor (T0, T1).
Primary Aim 2 Based on T1 data only, we will examine
how changes in smoking behavior affected THS pollu-
tion in dust. This hypothesis will be tested using a multi-
variate multiple linear regression model with TSNA
levels in dust as the response variables and change in
smoking behavior, number of remaining smokers, num-
ber of cigarettes smoked, and home smoking restrictions
as explanatory variables. Categorical explanatory vari-
ables will be dummy-coded and possible interaction ef-
fects with child sex and age will be explored. Overall
model fit statistics and tests will be evaluated and spe-
cific hypothesis tests will be conducted for each of the
explanatory variables of interest. If standard ordinary
least squares models are found to not be appropriate, we
will rely on corresponding maximum likelihood estima-
tion models and their fit indices and hypothesis tests.
At T2, we will collect data from N=30 homes of quitters
or those who have confirmed home smoking bans (based
on air nicotine levels) and N=30 homes of continued
smokers. Because of the relatively small sample size, mean
levels of groups of pollutant concentrations (e.g., oxy
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PAHs, nitro-PAHs, TSNAs) will be compared at T1 and
T2 via paired sample parametric or nonparametric tests.
Primary aim 3 We will extract clinical data from the
EMRs of the T0 visit of the 200 participants from Aim 1.
We will use EMR data to assess frequencies and types of
emergency care visits that these 200 smoke exposed chil-
dren had for 6-months prior to T0 compared to Epic
data from an age and 6-month time period-matched
sample of 200 non-smoke exposed children (from
R21CA184337) [21]. Descriptive statistics will be exam-
ined, including frequencies and percentages for categor-
ical variables and means and standard deviations for
continuous variables. Missing values and outliers will be
checked and verified. The distributional properties of
the outcome variables defining THS and OTS exposure
will also be examined to see if transformation will be re-
quired for analysis purposes. Multiple linear regression
models and t tests will be used to examine associations
between home environment and THS and OTS levels,
respectively, and EMR data from T0, including sociode-
mographics, past medical history, ICD-10 diagnosis,
positive ancillary test results, interventions, medications
given, and disposition. Multiple linear regression models
will also be conducted to investigate factors predicting
exposure levels. Linear models for dichotomous (logistic)
and count outcomes (Poisson or Negative Binomial) will
be used to examine the association between exposure
and respiratory-related illness and health care utilization
variables, controlling for child age, home type and rele-
vant sociodemographic and clinical variables.
Missing data We will follow guidelines as per Little et.
al [43], to minimize attrition and optimize the use of all
data, although there may still be bias with respect to the
selected subjects. Collection of sociodemographic infor-
mation on those included and excluded allows us to ad-
just statistical models for appropriate covariates.
Data safety monitoring plan (DSMP)
We do not anticipate risk of interventions; however a
DSMP has been maintained for all participants as part of
R01HD083354. Validity and integrity of the data is being
ensured by appropriate research design, use of pretested
tools for data collection and by quality assurance.
Data confidentiality and archiving
We will strictly maintain the privacy, anonymity, and con-
fidentiality of the data and samples we have and are col-
lecting. In order to protect the safety of participants, study
data and samples are protected by a Certificate of Confi-
dentiality and are stored securely at CCHMC. Coded
identification numbers are used to anonymize and
depersonalize the data. The linking code, electronic data
files and any paper forms are stored in a separate location
under password protections or lock and key. Access to the
data and samples are limited to authorized study staff.
Dissemination policy
The project results will be published regardless of the
outcome upon approval from all investigators.
Project update
Baseline data collection and implementation of interven-
tions commenced April 2016 and are currently ongoing.
Initial follow-up home visits commenced in May 2016
and are currently ongoing.
Discussion
This study is based on a growing body of research dem-
onstrating that exposure to tobacco smoke toxicants
among nonsmokers is not limited to inhaling SHS, the
mixture of exhaled mainstream smoke and sidestream
smoke. Nonsmokers may also be exposed to the residue
of SHS compounds left behind on surfaces, in dust, and
embedded in materials long after cigarettes have been
smoked. Because of the physical and chemical properties
of its constituents, SHS easily spreads throughout differ-
ent rooms of a home, to neighboring apartments, and to
different floors of a larger building. Commonly referred
to as THS, this residue is pervasive throughout indoor
environments where tobacco products have been used
and can be found in carpets, pillows, walls, desks, uphol-
stery and even on the hands of nonsmokers living in
such THS polluted environments. The pervasiveness of
THS in dust and on surfaces allows for exposure
through dermal transfer and ingestion, pathways typic-
ally not considered for SHS exposure. Because young
children are often in closer contact with their physical
environment than adults (e.g., crawling playing on the
ground, pica behavior), they are at particular risk of ex-
posure to THS that accumulates in dust and on surfaces.
Utilizing this unique sample of smoke-exposed children,
this project will be the first to differentiate the individual
and collective contribution of SHS and THS to overall
OTS. The results will identify the types, levels, markers of,
and health risks of tobacco toxicants. This research can po-
tentially change how we protect children from all forms of
tobacco smoke exposure, by recognizing that SHS and
THS needs to be addressed separately as sources of
pollution and exposure. Results will be used to de-
velop remediation strategies to more completely pro-
tect children from dangerous tobacco toxicant-related
exposures. The effect of the implementation of these
THS reduction strategies on OTS levels and child
health will be tested in future trials.
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